Stock A001360 SAMSUNG PHARM. CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Total Return chart SAMSUNG PHARM. Co., LTD.

Equities

A001360

KR7001360007

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-16 EDT 		5-day change 1st Jan Change
1,693 KRW +0.12% Intraday chart for SAMSUNG PHARM. Co., LTD. -0.59% -22.16%
2023 NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd. CI
2023 NEXTURNBIOSCIENCE Co., Ltd. announced that it expects to receive KRW 9 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd. CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

Past dividends on SAMSUNG PHARM. Co., LTD.

1997-01-02 Annual 100 KRW
1996-01-02 Annual 150 KRW
1995-01-02 Annual 250 KRW
1994-01-02 Annual 250 KRW
1993-01-03 Annual 250 KRW
  1. Stock Market
  2. Equities
  3. A001360 Stock
  4. Charts SAMSUNG PHARM. Co., LTD.
  5. Total Return chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW